Search for: "BENEFIT v. PFIZER, INC." Results 1 - 20 of 201
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2024, 9:05 pm by renholding
In Panuwat, the defendant was an employee of Medivation, Inc., a mid-cap oncology firm that was resisting one hostile bidder (Sanofi S.A.) and encouraging another firm (Pfizer) to outbid Sanofi. [read post]
19 Oct 2023, 8:59 am by Robin E. Kobayashi
[LexisNexis Commentary: This IMR is particularly interesting because the medication Geodon, which was at issue here, was the subject of a $301 million settlement between Pfizer, Inc. and the U.S. [read post]
20 Jun 2023, 5:55 am by Jennifer Papapanagiotou
Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUAs) for the Pfizer, Inc. and the ModernaTX, Inc. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
Why would a pharmacy benefit manager (PBM) voluntarily agree to place Horizon’s drugs Krystexxa and Tepezza in a preferred section of the formulary and exclude the benefits of competition for those products if it did not receive rebates that fully offset those losses? [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
Why would a pharmacy benefit manager (PBM) voluntarily agree to place Horizon’s drugs Krystexxa and Tepezza in a preferred section of the formulary and exclude the benefits of competition for those products if it did not receive rebates that fully offset those losses? [read post]
14 Feb 2023, 12:29 pm
Becoming familiar with IP protection types can greatly benefit your business. [read post]
3 Jan 2023, 1:47 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
2 Sep 2022, 5:01 am by Eugene Volokh
Still, the core point remains, either as an Establishment Clause argument or at least as a policy argument: The benefits to some religious observers (or at least to some people who have family members within religious communities) come to the expense of the information access rights of other religious observers. [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 48. [12] See Free World Trust, supra, at paragraph 13; Apotex Inc v Wellcome Foundation Ltd, 2002 SCC 77 at paragraph 37, [2002] 4 SCR 153; AstraZeneca Canada Inc v Apotex Inc, 2017 SCC 36 at paragraph 39, [2017] 1 SCR 943 [13] See Free World Trust, supra, at paragraphs 33–43; applied in Seedlings Life Science Ventures, LLC v. [read post]
13 Aug 2019, 6:03 am
PepsiCo, Inc. regarding whether use of another’s trademark in a marketing slogan is fair use. [read post]